Innovative Bioresearch - platform for support of researches in the sphere searching ways treatment AIDS and cancer.

Despite the enormous steps of progress, in the 21st century, humanity continues to suffer from such terrible diseases as HIV / AIDS and cancer. Like the plague HIV and cancer have taken many human lives. But the most critical difference, surpassing plague, is that from HIV and cancer of medicines have not been invented yet. However, if we draw a parallel to the end, people for a long time couldn't cure of plague, but now it is treated in 95% of cases. Today, a large number of talented scientists around the world are conducting daily research and are trying to fight HIV and cancer, but they still have not invented those drugs that will eventually defeat these viruses.

On this today, we will talk about the Italian biotechnology campaign Innovative Bioresearch which is trying to solve these complex problems that all humanity and this campaign are facing. The primary goal of Innovative Bioresearch is the introduction of innovations in the fight against HIV, cancer and human regeneration. ICO is established to raise funds for the support of medical research by Innovative Bioresearch. Every year medical technologies take steps forward, bringing hope to those who suffer from severe and debilitating diseases and Innovative Bioresearch will help to make a breakthrough in this area.

Researches about HIV/AIDS which are conducted by the company
HIV infection leads to a gradual decrease in the functionality of the immune system and decline in the number of CD4 + T cells. Over time, this causes the development of AIDS. There are several hypotheses why the virus strongly affects the tropism of SupT1 cells. Jonathan Fior offers the infusion of irradiated SuP T1 cells as a cell therapy for HIV to use the therapeutic potential of this phenomenon. The rationale for this approach is that the transfer of infection to inoculated cells must prevent infection and depletion of CD4 + T cells in patients.
Cellular therapy unlike from traditional medicinal methods will have a set of advantages:

• effect of vaccination;
• the absence of toxic threat for internals;
• high level of effectiveness for patients at the final stage of the disease, who developed drug-resistant and very aggressive strains of HIV;
• the possibility of treatment by new molecular bonds, such as Vif-inhibitor, for impact on HIV infection tanks in an organism.

The study of regeneration technologies based on the model salamander.
Creators of the project suggest using fibroblasts of a salamander for treatment of dangerous diseases with which the humanity doesn't cope yet. Among vertebrates, urodele amphibians (salamanders) are the only quadrupeds able to regenerate complex structures, such as limbs, tail and spinal cord throughout their life. Also, was proved that the salamander regeneration process eliminates tumors.
Fibroblasts are necessary for the regeneration of the salamander, but the mechanisms underlying regeneration remain unclear. The role of fibroblasts in the regeneration of the extremities of the salamander and their activity compared with human fibroblasts.
Thus, many scientists have suggested that salamanders are resistant to the development of cancer. It led to the use of the model of these animals as a platform for cancer research.
Numerous studies have shown that these animals perfect cope with various types of cancer. All attempts to instill into them tumor cells failed. The salamander's organism copes with such a problem perfect. A deeper understanding of these processes can lead to the development of new regenerative and anticancer therapies.

Besides the company plans to frame the decentralized database based on blockchain technologies. The main advantages of the decentralized database include:

• accessibility information from any place;
• security through the use of smart contracts, which prevents fraud with the addition of incorrect data in the blockchain.

It will be possible due to the creation of unique application equipped with an easy-to-use interface allowing entering into the database a wide range of individual parameters of each patient (age, height, disease stage, ethnicity, etc.), treatment results and clinical protocols.
The application will develop, analyze and create recommended treatment profiles for each patient, thus eliminating the need to manually process large amounts of data, as in currently existing centralized clinical databases. The "You're not alone" app will to document the progress of research projects on the treatment of diseases, as well as carry out regular updates and publish articles. Also, will be created community in which people with HIV will be able to communicate with each other, leave comments and consult with specialists. The app will also provide information on all current clinical trials, how to participate in them and about the full list of medical institutions offering treatment.

The company challenges the most critical problems of modern humanity, such as HIV / AIDS and cancer! In addition to carrying out ICO to raise funds for the development of the project, the team intends to create the first source of revenue for research funding by launching JDM Online Garage service of announcements about car sales for platform tokens. The JDM Online Garage service will offer not only sales of cars such brands as Subaru, Skyline and Supra but will also ensure their delivery to anywhere in the world.
Another way to create a stable and constant flow of funds for research will be the placement of advertisements specific HIV-related products (for example, PrEP drugs). According to preliminary estimates, with attendance of about 25,000 per day, this will provide an average income of about $ 50,000. The authors of the project note that crucial point in their case is that they aimed at demonstrating advertising solely for the target audience, which will increase its effectiveness compared to conventional advertising campaigns on third-party sites.

ICO
Platform: Ethereum
Type: ERC20
Pre ICO Price: 1 ETH = 498 INNBC
Price ICO: 1 ETH = 415INNBC
Soft cap pre: -ICO: 20 million INNBC
Soft cap: 30 million INNBC
Hard cap: 50 million INNBC
Pre ICO: 01.05.2018 - 15.06.2018. (20% bonus)
ICO: 16.06.2018 - 01.08.2018

How pleasant it is to realize that in a short time humanity is learning to fight all diseases and prevent them in advance. Innovative Bioresearch is a project that every one of us needs! In this direction, massive changes and innovations are happening now, and with the advent of Innovative Bioresearch, this industry can significantly change. We must support such projects and monitor their development. The project has perspective, and more than 18,000 people have already expressed an interest in buying platform tokens. Let's wish good luck to the developers and let's make our world better!

Learn more about Innovative Bioresearch:
Website - https://www.innovativebioresearch.com/
Whitepaper - https://docs.wixstatic.com/ugd/b25952_f15e84ff60ea49879619ed747a40b54e.pdf
BitcoinTalk - https://bitcointalk.org/index.php?topic=3378302
Twitter - https://twitter.com/InnBioresearch
Facebook - https://www.facebook.com/innovativebioresearch
Telegram - https://t.me/innovativebioresearch

My bitcointalk profile: https://bitcointalk.org/index.php?action=profile;u=1286131
0x9EBF42b07878140Bfa8442A09B2257Be6F172182